Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
mBio ; 11(2)2020 03 24.
Article in English | MEDLINE | ID: mdl-32209696

ABSTRACT

The appressoria that are generated by the rice blast fungus Magnaporthe oryzae in response to surface cues are important for successful colonization. Previous work showed that regulators of G-protein signaling (RGS) and RGS-like proteins play critical roles in appressorium formation. However, the mechanisms by which these proteins orchestrate surface recognition for appressorium induction remain unclear. Here, we performed comparative transcriptomic studies of ΔMorgs mutant and wild-type strains and found that M. oryzae Aa91 (MoAa91), a homolog of the auxiliary activity family 9 protein (Aa9), was required for surface recognition of M. oryzae We found that MoAA91 was regulated by the MoMsn2 transcription factor and that its disruption resulted in defects in both appressorium formation on the artificial inductive surface and full virulence of the pathogen. We further showed that MoAa91 was secreted into the apoplast space and was capable of competing with the immune receptor chitin elicitor-binding protein precursor (CEBiP) for chitin binding, thereby suppressing chitin-induced plant immune responses. In summary, we have found that MoAa91 is a novel signaling molecule regulated by RGS and RGS-like proteins and that MoAa91 not only governs appressorium development and virulence but also functions as an effector to suppress host immunity.IMPORTANCE The rice blast fungus Magnaporthe oryzae generates infection structure appressoria in response to surface cues largely due to functions of signaling molecules, including G-proteins, regulators of G-protein signaling (RGS), mitogen-activated protein (MAP) kinase pathways, cAMP signaling, and TOR signaling pathways. M. oryzae encodes eight RGS and RGS-like proteins (MoRgs1 to MoRgs8), and MoRgs1, MoRgs3, MoRgs4, and MoRgs7 were found to be particularly important in appressorium development. To explore the mechanisms by which these proteins regulate appressorium development, we have performed a comparative in planta transcriptomic study and identified an auxiliary activity family 9 protein (Aa9) homolog that we named MoAa91. We showed that MoAa91 was secreted from appressoria and that the recombinant MoAa91 could compete with a chitin elicitor-binding protein precursor (CEBiP) for chitin binding, thereby suppressing chitin-induced plant immunity. By identifying MoAa91 as a novel signaling molecule functioning in appressorium development and an effector in suppressing host immunity, our studies revealed a novel mechanism by which RGS and RGS-like proteins regulate pathogen-host interactions.


Subject(s)
Ascomycota/pathogenicity , Chitin/metabolism , Fungal Proteins/metabolism , Host-Pathogen Interactions/immunology , Oryza/immunology , Plant Immunity , Ascomycota/genetics , Fungal Proteins/genetics , Gene Expression Profiling , Gene Expression Regulation, Fungal , Oryza/microbiology , Plant Diseases/microbiology , Signal Transduction , Virulence
2.
Fungal Genet Biol ; 137: 103349, 2020 04.
Article in English | MEDLINE | ID: mdl-32006681

ABSTRACT

MicroRNAs (miRNAs) play important roles in various cellular growth and developmental processes through post-transcriptional gene regulation via mRNA cleavage and degradation and the inhibition of protein translation. To explore if miRNAs play a role in appressoria formation and virulence that are also governed by the regulators of G-protein signaling (RGS) proteins in the rice blast fungus Magnaporthe oryzae, we have compared small RNA (sRNA) production between several ΔMorgs mutant and the wild-type strains. We have identified sRNA236 as a microRNA-like milR236 that targets the encoding sequence of MoHat1, a histone acetyltransferase type B catalytic subunit involved in appressorium function and virulence. We have also found that milR236 overexpression induces delayed appressorium formation and virulence attenuation, similar to those displayed by the ΔMohat1 mutant strain. Moreover, we have shown that the transcription factor MoMsn2 binds to the promoter sequence of milR236 to further suppress MoHAT1 transcription and MoHat1-regulated appressorium formation and virulence. In summary, by identifying a novel regulatory role of sRNA in the blast fungus, our studies reveal a new paradigm in the multifaceted regulatory pathways that govern the appressorium formation and virulence of M. oryzae.


Subject(s)
Ascomycota/genetics , Histone Acetyltransferases/genetics , Ascomycota/metabolism , Ascomycota/pathogenicity , DNA-Binding Proteins/metabolism , Fungal Proteins/genetics , Gene Expression Regulation, Fungal/genetics , Histone Acetyltransferases/metabolism , Magnaporthe/genetics , Magnaporthe/pathogenicity , MicroRNAs/genetics , MicroRNAs/metabolism , Oryza/microbiology , Plant Diseases/microbiology , Saccharomyces cerevisiae Proteins/metabolism , Signal Transduction/genetics , Spores, Fungal/growth & development , Transcription Factors/genetics , Transcription Factors/metabolism , Virulence
3.
J Neurochem ; 113(5): 1073-91, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20236390

ABSTRACT

Abnormal expansion of a polyglutamine tract in huntingtin (Htt) protein results in Huntington's disease (HD), an autosomal dominant neurodegenerative disorder involving progressive loss of motor and cognitive function. Contrasting with the ubiquitous tissue expression of polyglutamine-expanded Htt, HD pathology is characterized by the increased vulnerability of specific neuronal populations within the striatum and the cerebral cortex. Morphological, biochemical, and functional characteristics of neurons affected in HD that might render these cells more vulnerable to the toxic effects of polyglutamine-Htt are covered in this review. The differential vulnerability of neurons observed in HD is discussed in the context of various major pathogenic mechanisms proposed to date, and in line with evidence showing a 'dying-back' pattern of degeneration in affected neuronal populations.


Subject(s)
Huntington Disease/pathology , Neurons/pathology , Axonal Transport/physiology , Brain/pathology , Brain Chemistry/physiology , Brain-Derived Neurotrophic Factor/genetics , Brain-Derived Neurotrophic Factor/physiology , Gene Expression/genetics , Gene Expression/physiology , Humans , Huntingtin Protein , Huntington Disease/etiology , Huntington Disease/genetics , Mitochondria/pathology , Mutation/physiology , Nerve Degeneration/pathology , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/toxicity , Neurons/classification , Nuclear Proteins/genetics , Nuclear Proteins/toxicity , Signal Transduction
4.
Nat Neurosci ; 12(7): 864-71, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19525941

ABSTRACT

Selected vulnerability of neurons in Huntington's disease suggests that alterations occur in a cellular process that is particularly critical for neuronal function. Supporting this idea, pathogenic Htt (polyQ-Htt) inhibits fast axonal transport (FAT) in various cellular and animal models of Huntington's disease (mouse and squid), but the molecular basis of this effect remains unknown. We found that polyQ-Htt inhibited FAT through a mechanism involving activation of axonal cJun N-terminal kinase (JNK). Accordingly, we observed increased activation of JNK in vivo in cellular and mouse models of Huntington's disease. Additional experiments indicated that the effects of polyQ-Htt on FAT were mediated by neuron-specific JNK3 and not by ubiquitously expressed JNK1, providing a molecular basis for neuron-specific pathology in Huntington's disease. Mass spectrometry identified a residue in the kinesin-1 motor domain that was phosphorylated by JNK3 and this modification reduced kinesin-1 binding to microtubules. These data identify JNK3 as a critical mediator of polyQ-Htt toxicity and provide a molecular basis for polyQ-Htt-induced inhibition of FAT.


Subject(s)
Axonal Transport/physiology , Kinesins/metabolism , Mitogen-Activated Protein Kinase 10/metabolism , Nerve Tissue Proteins/metabolism , Peptides/metabolism , Serotonin Plasma Membrane Transport Proteins/metabolism , Animals , Cell Line , Decapodiformes , Disease Models, Animal , Gene Knock-In Techniques , Hippocampus/metabolism , Humans , Kinesins/genetics , Mice , Mice, Transgenic , Microtubules/metabolism , Mitogen-Activated Protein Kinase 8/metabolism , Mitogen-Activated Protein Kinase 9/metabolism , Mutation , Neurons/physiology , Peptides/genetics , Phosphorylation , Serotonin Plasma Membrane Transport Proteins/genetics
5.
Biochemistry ; 47(15): 4535-43, 2008 Apr 15.
Article in English | MEDLINE | ID: mdl-18361505

ABSTRACT

Conventional kinesin is a major microtubule-based motor protein responsible for anterograde transport of various membrane-bounded organelles (MBO) along axons. Structurally, this molecular motor protein is a tetrameric complex composed of two heavy (kinesin-1) chains and two light chain (KLC) subunits. The products of three kinesin-1 (kinesin-1A, -1B, and -1C, formerly KIF5A, -B, and -C) and two KLC (KLC1, KLC2) genes are expressed in mammalian nervous tissue, but the functional significance of this subunit heterogeneity remains unknown. In this work, we examine all possible combinations among conventional kinesin subunits in brain tissue. In sharp contrast with previous reports, immunoprecipitation experiments here demonstrate that conventional kinesin holoenzymes are formed of kinesin-1 homodimers. Similar experiments confirmed previous findings of KLC homodimerization. Additionally, no specificity was found in the interaction between kinesin-1s and KLCs, suggesting the existence of six variant forms of conventional kinesin, as defined by their gene product composition. Subcellular fractionation studies indicate that such variants associate with biochemically different MBOs and further suggest a role of kinesin-1s in the targeting of conventional kinesin holoenzymes to specific MBO cargoes. Taken together, our data address the combination of subunits that characterize endogenous conventional kinesin. Findings on the composition and subunit organization of conventional kinesin as described here provide a molecular basis for the regulation of axonal transport and delivery of selected MBOs to discrete subcellular locations.


Subject(s)
Kinesins/chemistry , Animals , Antibodies/immunology , Dimerization , Holoenzymes/analysis , Holoenzymes/chemistry , Holoenzymes/immunology , Intracellular Membranes/chemistry , Kinesins/analysis , Kinesins/immunology , Mice , Microsomes/chemistry , Protein Subunits/analysis , Protein Subunits/chemistry , Protein Subunits/immunology
6.
Nat Neurosci ; 9(7): 907-16, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16751763

ABSTRACT

Expansion of the polyglutamine (polyQ) stretch in the androgen receptor (AR) protein leads to spinal and bulbar muscular atrophy (SBMA), a neurodegenerative disease characterized by lower motor neuron degeneration. The pathogenic mechanisms underlying SBMA remain unknown, but recent experiments show that inhibition of fast axonal transport (FAT) by polyQ-expanded proteins, including polyQ-AR, represents a new cytoplasmic pathogenic lesion. Using pharmacological, biochemical and cell biological experiments, we found a new pathogenic pathway that is affected in SBMA and results in compromised FAT. PolyQ-AR inhibits FAT in a human cell line and in squid axoplasm through a pathway that involves activation of cJun N-terminal kinase (JNK) activity. Active JNK phosphorylated kinesin-1 heavy chains and inhibited kinesin-1 microtubule-binding activity. JNK inhibitors prevented polyQ-AR-mediated inhibition of FAT and reversed suppression of neurite formation by polyQ-AR. We propose that JNK represents a promising target for therapeutic interventions in SBMA.


Subject(s)
Axonal Transport/physiology , JNK Mitogen-Activated Protein Kinases/physiology , Peptides/metabolism , Receptors, Androgen/genetics , Receptors, Androgen/metabolism , Trinucleotide Repeat Expansion , Analysis of Variance , Animals , Axonal Transport/drug effects , Blotting, Western/methods , Cell Fractionation/methods , Cell Line, Tumor , Decapodiformes/cytology , Dose-Response Relationship, Drug , Drug Interactions , Enzyme Inhibitors/pharmacology , Humans , Immunohistochemistry/methods , Microtubules/metabolism , Neuroblastoma , Phosphorylation , Protein Binding/drug effects , Protein Binding/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...